Please select the eligibility criteria that correspond to the clinical trial below.
Title: The Personal Health Care Partner Project, Conversational IT for Better, Safer Pediatric Primary Care
Brief Summary: Interactive telephony technologies offer a potentially highly effective, patient-centered communication modality by guiding parents at home through interactive discussions that can gather information and actively reinforce recommendations and treatments. Interactive telephony systems are particularly well suited for use in vulnerable populations since access to the telephone is nearly universal, and the system does not rely on reading printed text. The investigators propose to develop and evaluate an integrated patient-centered health information system, the Personal Health Partner (PHP). The PHP will use fully automated, interactive, conversations to gather personal health data and counsel parents before scheduled visits, exchange that data with the child's primary care clinician via the electronic health record (EHR), and offer personalized follow-up assessment and counseling after visits. The information technology-based approach to be evaluated in this project will link parents and children outside the clinical setting with their primary care center and will offer comprehensive assessments AND counseling to reinforce and support parental behavior change.


Options:
A: Inclusion Criteria:

* Parents of children will be enrolled in the study if they meet a set of eligibility criteria which includes:

  1. Age 0 - 11 years old
  2. A primary care patient at Boston Medical Center
  3. An English speaking child and parent.

Exclusion Criteria:

* Children will be considered ineligible for the study if they plan to move away from the Boston area in less than 3 months, or are participating in another primary care research project with content that overlaps the content within this study. Currently, there are no studies being conducted that would lead to exclusion.
B: Inclusion Criteria:

* High blood pressure that is being treated with medication
* BMI between 30 and 50 kg/m2
* Weighs no more than 400 lbs
* Willing to change diet, physical activity levels, and weight
* Willing to be assigned to either study group
* Patient of a participating community health center with a record of at least one medical visit in the 12 months before study entry
* Primary care provider approval is needed for people with the following conditions: diabetes mellitus, a prior cardiovascular event more than 6 months before study entry, known stable cardiovascular or peripheral vascular disease

Exclusion Criteria:

* Experienced a heart attack, stroke, or an atherosclerotic cardiovascular disease (ASCVD) procedure in the 6 months before study entry
* Serious medical condition that is likely to interfere with an accurate measurement of weight, for which weight loss is not medically advisable, or that would cause weight loss (e.g., end-stage renal disease \[ESRD\] and on dialysis; diagnosis or treatment for cancer in the 2 years before study entry, other than non-melanoma skin cancer)
* Prior or planned bariatric surgery
* Use of FDA-approved prescription weight loss medication, including off label drugs (e.g., topiramate, bupropion, byetta) or over-the-counter orlistat in the 6 months before study entry
* Long-term use (i.e., in the 6 months before study entry) of medications likely to cause weight gain or prevent weight loss (e.g., corticosteroids, lithium, olanzapine, risperidone, clozapine)
* Pregnant or breastfeeding in the 6 months before study entry
* Plans to become pregnant in the 2 years after study entry
* Plans to relocate from the area in the 2 years after study entry
* Another member of household is a study participant or study staff member
* Principal investigator decides that the individual is not suitable for the study
C: Inclusion Criteria:

* Age ≥ 21 years

  * BMI 30-50 kg/m2 and weight ≤ 400 lbs.
  * At least 2 of 5 criteria for metabolic syndrome

    * Elevated waist circumference (\> 102 cm for men, \> 88 cm for women)
    * Elevated blood pressure (≥ 130/85 mmHg)
    * Impaired fasting glucose (≥ 100 mg/dl)
    * Elevated triglycerides (≥ 150 mg/dl)
    * Low HDL cholesterol (\< 40 for men, \< 50 mg/dl for women)
  * Willing to change diet, physical activity and weight
  * Willing to accept randomization to each group
  * Able to give informed consent
  * Patient of participating PCP

Persons with the following conditions are eligible with PCP approval:

* Diabetes mellitus
* Prior CVD event \> 6 months before randomization
* Stable CVD or peripheral vascular disease

Exclusion Criteria:

* Serious medical condition likely to hinder accurate measurement of weight, or for which weight loss is contraindicated, or which would cause weight loss (e.g., end-stage renal disease on dialysis, cancer diagnosis or treatment within 2 yrs)
* Prior or planned bariatric surgery
* Chronic use (at least past 6 months) of medications likely to cause weight gain or prevent weight loss (e.g. corticosteroids, lithium, olanzapine, risperidone, clozapine)
* Unintentional weight loss within 6 months of enrollment (≥ 5% of body weight)
* Intentional weight loss within 6 months of enrollment (≥ 5% of body weight)
* Pregnant or nursing within past 6 months
* Plans to relocate from the area within 2 years
* Another member of household is a study participant or staff in the trial
* Consumes \> 14 alcoholic drinks per week
* Current use of illicit substances
* Psychiatric hospitalization in last year
* Psychiatric condition likely to impair adherence to treatment (e.g., schizophrenia)
* Blood pressure ≥ 160/100 mmHg; patient may be re-screened in 1 month
* Principal Investigator or PCP discretion
D: Inclusion Criteria:

* have type 2 diabetes
* have a HbA1c equal to or \> 8.0%
* must speak English, Spanish, or Cantonese.

Exclusion Criteria:

* Dementia
* Psychosis/Schizophrenia
* End Stage Renal Disease

Answer: A